COVID-19 Vaccine Reaches Phase I Clinical Trial
Open-label trial of new Ad5 vectored COVID-19 vaccine found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans. The creation of an effective vaccine is...